Generic Name
Tetracyclines
(tetracycline, minocycline, doxycycline, demeclocycline)
Dosing and Formulations
- Short acting (6-12h):
- Tetracycline 250-1500mg / day (daily-BID),
- Intermediate (16hrs)
- Doxycycline 50-200 mg/ day (daily-BID), Minocycline IR 50-200 mg/day (daily-BID), Demeclocycline
- Long-acting – not to be used for infections (18-22hrs)
- Doxycycline MR 40mg qd
- Minocycline ER 1mg/kg/d
Mechanism of Action
Binds 30S subunit of bacterial ribosome decreasing protein synthesis
gram positive > gram negative, Mycoplasma, rickettsia, spirochetes, some parasites
Anti-inflammatory effects
- Decrease neutrophil chemoattractants (peptide chemotactic factor, lipase) production by C. acnes which decrease neutrophil migration
- Inhibits granuloma formation (inhibits Protein kinase C)
- Inhibits matrix metalloproteinases
- Downregulates cytokines involved in innate response
- Scavenger effect against reactive oxygen species
Lipophilic: accumulates in the pilosebaceous unit
Pharmacokinetics:
- Food and high pH agents (e.g., antacids) decrease tetracycline absorption; therefore, should take 2 hours after food, others tetracyclines can be taken with food
- Absorption decreased if taking polyvalent cations (laxatives, antacids, dietary supplements, dairy) causing chelation, mainly with tetracycline > doxycycline > minocycline
- Renal failure prolongs half-life (except doxycycline as it is excreted mostly in bile)
Indications
- Acne (see discussion below)
- Rosacea (doxycycline MR 40 only one that is FDA approved)
- ocular rosacea, perioral dermatitis
- immuno-bullous diseases (Bullous pemphigoid, linear IgA bullous dermatosis, Pemphigus vulgaris and foliaceus),
- Granulomatous diseases (sarcoidosis)
- Other: confluent and reticulated papillomatosis (minocycline), PLEVA, Lyme, ehrlichiosis (1st line for rickettsial diseases)
- Also indicated for community-acquired MRSA, Mycobacterium avium complex, sexually transmitted and blood-borne infections, bartonellosis, etc
Systemic antibiotics in acne:
- moderate/severe inflammatory acne resistant to topicals
- doxycycline and minocycline are equal and superior to tetracycline
- treatment for 3-4 months
- combine with topicals
- if patient cannot take tetracyclines, give: azithromycin, erythromycin or trimethoprim sulfamethoxazole (but these are 2nd line)
Contraindications:
- Pregnancy (teeth staining, and hypoplastic bone development)
- Children < 8 years old
- Renal disease (except doxycycline which can be used)
Liver disease: caution with doxycyline
Adverse Effects
- Gastrointestinal: nausea, pill esophagitis (especially doxycycline), hepatitis, pancreatitis
- Vestibular: dizziness, tinnitus, vertigo (these ones mainly with minocycline), pseudotumor cerebri (if persistent, can lead to permanent vision loss)
- hematologic: thrombocytopenia, neutropenia
- pregnancy: affects fetal teeth, bones (but rare with doxycycline); children <9 years of age 🡪 yellowish staining of teeth and bone developmental abnormalities
Cutaneous side effect
- Hypersensitivity: urticaria, fixed drug eruption, Sweets, Serum sickness-like reaction (minocycline mainly, especially if HIV), SJS/TEN, DRESS (minocycline)
- Autoimmune (minocycline >> others): autoimmune hepatitis, SLE-like reaction (typically anti-dsDNA positive > anti-histone Ab), ANCA vasculitis (PAN); can have delayed onset x years
- Photosensitivity (demeclocycline > doxycycline >> others), also photo-onycholysis
- Infections (gram negative folliculitis)
- dyspigmentation of skin, nails, teeth, bones, mucosa, sclera (minocycline)
- Type I: blue-black in scars (iron)
- Type II: blue-gray shins (melanin + iron)
- Type III: diffuse muddy brown on sun exposed (melanin)
Drug interactions
- Increase effects of warfarin, lithium, theophylline, digoxin, methotrexate, insulin
- Increase likelihood pseudotumor cerebri if taken with retinoids
Other
- Most common antibiotic used in dermatology
- To reduce gastrointestinal symptoms, instruct patients to take with glass of water and no reclining for 1 hour
- ANA positivity during treatment does not correlate with autoimmune disease, most of these patients do not develop clinical disease
- For acne, you see improvement after 3 weeks, and maximum benefit at 3-6 months
- New studies show efficacy of doxycycline 20 mg BID is similar to 100 mg BID in clearing inflammatory acne
- Resistance to tetracyclines can be seen (~20% acne patients), and occurs due to ribosomal protection (point mutation in genes encoding 16S ribosomal RNA) and drug efflux
- If a tetracycline must be given in pregnancy or in children (e.g. to treat early RMSF), use doxycline